FDA approves Pfizer's Litfulo for severe alopecia areata in teens and adults.
TL;DR
The FDA has approved the first and only medication for severe alopecia areata, or at least 50% hair loss, for Americans under 18. The once-daily pill called Litfulo, created by Pfizer, has shown to be effective in regaining hair coverage on the scalp. The approval will help substantiate alopecia areata as more than just something that’s cosmetic, which has been considered that for years by insurers who may not want to cover the therapies. A full year's supply has a list price of $49,000, according to Pfizer.
- FDA approves Litfulo, alopecia areata hair loss drug for teens 12+ USA TODAY
- FDA approves 1st treatment that can grow back hair for teens with alopecia areata GMA
- US FDA approves Pfizer's hair loss drug AOL
- FDA Approves Pfizer's LITFULO™ (Ritlecitinib) for Adults and Adolescents With Severe Alopecia Areata Business Wire
- FDA OKs Ritlecitinib for Ages 12 and Up for Alopecia Areata Medscape
- View Full Coverage on Google News
Want the full story? Read the original reporting
Read on USA TODAY